FDA, CDC, neurodiversity, Healthy Start: Morning Rounds
The recent FDA decision on the first priority voucher drug has raised concerns about political influence in the agency’s approval process. Instead of the usual individual reviewers making the decision, agency leaders were involved in the voting panel. This move has been criticized for potentially changing the dynamics of the decision-making process. Bioethics and law professor Holly Fernandez Lynch expressed her concerns about the commissioner’s involvement in the discussions.
In another study, it was found that 7 out of 10 people enrolled in Medicaid do not receive treatment within six months of being diagnosed with an opioid use disorder. The study, published in The American Journal of Drug and Alcohol Abuse, highlighted the challenges faced by Medicaid enrollees in accessing effective treatments like methadone and buprenorphine. With impending Medicaid cuts, the authors of the study are worried about the impact on people struggling with opioid use disorder.
The legalization of hemp products up to a certain THC concentration in 2018 is now under threat with the recent provision in the spending bill passed by Congress. This provision aims to ban all intoxicating THC products, potentially making all forms of marijuana illegal controlled substances. This move could have significant implications for individuals who rely on these products for their well-being.
The Healthy Start program, which provides support to families during and after pregnancy, is facing challenges as its funding is at risk of being eliminated for the third consecutive year. President Trump’s decision to fire every employee in HRSA’s Healthy Start division has further jeopardized the program’s future. Despite the invaluable support provided by Healthy Start case managers like Malaika Milele Gardner, the program is under threat of closure.
In a tribute to a former scientific leader at the CDC, Walter Dowdle, who passed away at the age of 94, his contributions to the field of microbiology and public health were acknowledged. Dowdle’s leadership at the CDC and his dedication to advancing infectious disease research were highlighted by former CDC director William Foege. A celebration of life will be held in honor of Dowdle’s legacy.
The neurodiversity movement, which advocates for acceptance and inclusion of individuals with neurological differences, is facing challenges in maintaining momentum. Jack Pemment, who is autistic, raised concerns about the movement’s vulnerability to attacks due to vague language and definitions. Pemment emphasized the importance of credible responses to counter potential criticisms and ensure the movement’s progress.
In other news, U.S. cancer registries are facing constraints in recognizing transgender patients, a personal essay on battling with blood, and the CDC’s decision to end telework for employees are topics being discussed in the healthcare and medical community. These issues highlight the ongoing challenges and developments in the field of health and medicine.
